Ember LifeSciences and Alfresa Corporation Enter into Capital and Business Alliance to Improve the Quality of the Pharmaceutical Cold Chain in Japan

Ember offers Japanese market pharmaceutical transportation solution integrating temperature control, visualization of transportation status and traceability LOS ANGELES, July 29, 2026 /PRNewswire/ -- Ember LifeSciences, Inc. ("Ember"), an award-winning provider of advanced pharmaceutical...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.